 |
| J&J Innovation's Ken Drazan |
Ken Drazan, head of J&J Innovation's California outpost, joins FierceBiotech Radio to discuss how the pharma giant approaches external R&D, how partnering has changed in modern biopharma and why med tech so often lags other fields in life sciences.
Download the episode on iTunes or Stitcher, or listen below--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]. And if you missed last week's talks with with Bloomberg Intelligence analyst Asthika Goonewardene and EP Vantage's Amy Brown, you can find them here.